State Street Corp Ocular Therapeutix, Inc Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, State Street Corp holds 3,476,292 shares of OCUL stock, worth $31.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,476,292

Previous 3,920,663 11.33%

Holding current value

$31.4 Million

Previous $26.8 Million 12.78%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$6.45 - $9.23 $2.87 Million - $4.1 Million	-444,371 Reduced 11.33%	3,476,292 $30.2 Million
Q2 2024 Aug 14, 2024	BUY	$4.2 - $8.69 $6.38 Million - $13.2 Million	1,518,283 Added 63.2%	3,920,663 $26.8 Million
Q1 2024 May 15, 2024	BUY	$3.85 - $10.93 $3.32 Million - $9.43 Million	862,805 Added 56.04%	2,402,380 $21.9 Million
Q4 2023 Feb 14, 2024	SELL	$2.08 - $4.52 $503,963 - $1.1 Million	-242,290 Reduced 13.6%	1,539,575 $6.87 Million
Q3 2023 Nov 14, 2023	BUY	$3.14 - $5.04 $645,747 - $1.04 Million	205,652 Added 13.05%	1,781,865 $5.6 Million
Q2 2023 Aug 14, 2023	BUY	$4.6 - $7.64 $382,968 - $636,060	83,254 Added 5.58%	1,576,213 $8.13 Million
Q1 2023 May 15, 2023	BUY	$2.79 - $6.27 $294,699 - $662,281	105,627 Added 7.61%	1,492,959 $7.87 Million
Q4 2022 Feb 14, 2023	SELL	$2.61 - $4.41 $31,356 - $52,981	-12,014 Reduced 0.86%	1,387,332 $3.9 Million
Q3 2022 Nov 15, 2022	SELL	$4.09 - $6.5 $51,047 - $81,126	-12,481 Reduced 0.88%	1,399,346 $5.81 Million
Q2 2022 Aug 15, 2022	SELL	$3.01 - $5.22 $882,252 - $1.53 Million	-293,107 Reduced 17.19%	1,411,827 $5.68 Million
Q1 2022 May 16, 2022	SELL	$4.83 - $7.35 $122,788 - $186,851	-25,422 Reduced 1.47%	1,704,934 $8.44 Million
Q4 2021 Feb 14, 2022	BUY	$6.16 - $12.07 $353,004 - $691,683	57,306 Added 3.43%	1,730,356 $12.1 Million
Q3 2021 Nov 15, 2021	SELL	$9.7 - $14.34 $634,593 - $938,151	-65,422 Reduced 3.76%	1,673,050 $16.7 Million
Q2 2021 Aug 16, 2021	BUY	$13.43 - $19.16 $2.97 Million - $4.23 Million	220,855 Added 14.55%	1,738,472 $24.7 Million
Q1 2021 May 17, 2021	BUY	$15.82 - $22.11 $991,328 - $1.39 Million	62,663 Added 4.31%	1,517,617 $24.9 Million
Q4 2020 Feb 16, 2021	BUY	$7.91 - $22.95 $2.42 Million - $7.01 Million	305,487 Added 26.58%	1,454,954 $30.1 Million
Q3 2020 Nov 10, 2020	BUY	$7.36 - $9.87 $1.79 Million - $2.4 Million	243,485 Added 26.88%	1,149,467 $8.75 Million
Q2 2020 Aug 14, 2020	BUY	$4.67 - $8.95 $419,277 - $803,539	89,781 Added 11.0%	905,982 $7.55 Million
Q1 2020 May 11, 2020	BUY	$3.95 - $7.4 $3.22 Million - $6.04 Million	816,201 New	816,201 $4.04 Million

Others Institutions Holding OCUL

# of Institutions

172

Shares Held

138M

Call Options Held

150K

Put Options Held

225K

View Full List

About OCULAR THERAPEUTIX, INC

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $694M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

More about OCUL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Ocular Therapeutix, Inc Transaction History